Exercise-Induced Polymorphic Ventricular Tachycardia in Adults Without Structural Heart Disease

American Journal of Cardiology

Volumn 101, Issue 8, 2008, Pages 1142-1146

  Tan, Justin Hong jie ^a   Scheinman, Melvin M ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; METOPROLOL; METOPROLOL SUCCINATE; NADOLOL; VERAPAMIL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE DURATION; ELECTROCARDIOGRAPHY; EXERCISE; FAMILY HISTORY; HEART RATE; HEART VENTRICLE ARRHYTHMIA; HUMAN; ONSET AGE; POLYMORPHIC VENTRICULAR TACHYCARDIA; PRIORITY JOURNAL; SYMPTOMATOLOGY; TREADMILL EXERCISE; TREATMENT RESPONSE;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; CALCIUM CHANNEL BLOCKERS; CATECHOLAMINES; EXERCISE; EXERCISE TEST; HEART RATE; HUMANS; MALE; MIDDLE AGED; TACHYCARDIA, SINUS; TACHYCARDIA, VENTRICULAR;

EID: 41349112275     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.11.066     Document Type: Article

References (11)

1. Leenhardt A., Lucet V., Denjoy I., Grau F., Ngoc D.D., and Coumel P. Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. Circulation 91 (1995) 1512-1519
2. Priori S.G., Napolitano C., Tiso N., Memmi M., Vignati G., Bloise R., Sorrentino V., and Danieli G.A. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 103 (2001) 196-200
3. Viskin S., and Belhassen B. Polymorphic ventricular tachyarrhythmias in the absence of organic heart disease: classification, differential diagnosis, and implications for therapy. Prog Cardiovasc Dis 41 (1998) 17-34
4. Francis J., Sankar V., Nair V.K., and Priori S.G. Catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm 2 (2005) 550-554
5. Fisher J.D., Krikler D., and Hallidie-Smith D.A. Familial polymorphic ventricular arrhythmias: a quarter century of successful medical treatment based on serial exercise-pharmacologic testing. J Am Coll Cardiol 34 (1999) 2015-2022
6. De Rosa G., Delogu A.B., Piastra M., Chiaretti A., Bloise R., and Priori S.G. Catecholaminergic polymorphic ventricular tachycardia: successful emergency treatment with intravenous propranolol. Pediatr Emerg Care 20 (2004) 175-177
7. Eisenberg S.J., Scheinman M.M., Dullet N.K., Finkbeiner W.E., Griffin J.C., Eldar M., Franz M.R., Gonzalez R., Kadish A.H., and Lesh M.D. Sudden cardiac death and polymorphous ventricular tachycardia in patients with normal QT intervals and normal systolic cardiac function. Am J Cardiol 75 (1995) 687-692
8. Scheinman M.M., and Lam J. Exercise-induced ventricular arrhythmias in patients with no structural cardiac disease. Annu Rev Med 57 (2006) 473-484
9. Woelfel A., Foster J.R., Simpson Jr. R.J., and Gettes L.S. Reproducibility and treatment of exercise-induced ventricular tachycardia. Am J Cardiol 53 (1984) 751-756
10. Woelfel A., Foster J.R., McAllister Jr. R.G., Simpson Jr. R.J., and Gettes L.S. Efficacy of verapamil in exercise-induced ventricular tachycardia. Am J Cardiol 56 (1985) 292-297
11. Rosso R., Kalman J.M., Rogowski O., Diamant S., Birger A., Biner S., Belhassen B., and Viskin S. Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm 4 (2007) 1149-1154